Table 1 STR profiling of thyroid carcinoma cell lines.

From: RETRACTED ARTICLE: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

 

Thyroid Carcinoma cell lines

HTH83*

CAL62**

SW1736**

OGK-M***

ATC351**

C643**

HTH7**

HTH74**

T238**

vWA

16,19

16

16,19

17

18

15,17

14,18

16,17

16,17

TPOX

8

8,9

11

8,9

8,11

11,12

11

8,10

8,11

TH01

6,9

7,9

6,9.3

6,10

7

9.3,10

9,9.3

8

7,9.3

D5S818

12

9,12

12,13

10,13

12,13

11,12

11

11,12

9,11

D13S317

11,13

12

11,12

10,12

11

8,10

11,14

12,13

12

D7S820

12

10

8,11

10,13

9,10

9,12

8,11

9

11,13

D16S539

11,12

12,13

11,12

9,12

9,11

9,13

9,13

9

11,12

CSF1PO

11

9,12

12

10,11

12

10,11

12

11,12

12, 13

AMEL

XY

X

X

XY

XY

XY

X

X

X

  1. *STR profile by us matched to ATCC results.
  2. **STR profile by us matched to University of Kentucky (Lexington), University of Uppsala (Sweden), University of Colorado Cancer Centre and Memorial Sloan-Kettering Cancer Centre.
  3. ***STR profile matched to original profile (33).
Back to article page